Vaginally Administered Versus Per Oral Misoprostol in Induction of Labour
Phase 4
Completed
- Conditions
- Labour Induction
- Interventions
- Drug: Misoprostol, modified-release pessaryDrug: Misoprostol, per-oral tablets
- Registration Number
- NCT02539199
- Lead Sponsor
- Tampere University Hospital
- Brief Summary
The purpose of this study is to investigate the effectiveness and safety of vaginally administered misoprostol (Misodel) versus per orally administered misoprostol (Cytotec) in induction of labour in nulliparous women.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 270
Inclusion Criteria
- Nulliparous
- Singleton at term pregnancy (>36+6 weeks)
- Unfavourable cervix (Bishop score < 6)
- Fetal cephalic position
Exclusion Criteria
- Pre-term pregnancy (<37 weeks)
- Multiple pregnancy
- Rupture of membranes
- Other than fetal cephalic position
- Intra-uterine growth retardation
- Severe pre-eclampsia
- Severe hypertension
- Previous cesarean section
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Misoprostol modified-release pessary Misoprostol, modified-release pessary - Misoprostol, per-oral tablets Misoprostol, per-oral tablets -
- Primary Outcome Measures
Name Time Method Cesarean section rate at time of child birth
- Secondary Outcome Measures
Name Time Method The time from beginning of induction to child birth up to child birth Neonatal Apgar score 1, 5, 10 minutes after child birth
Trial Locations
- Locations (5)
Helsinki University hospital
🇫🇮Helsinki, Finland
Turku University Hospital
🇫🇮Turku, Finland
Kuopio University Hospital
🇫🇮Kuopio, Finland
Oulu University Hospital
🇫🇮Oulu, Finland
Tampere University Hospital
🇫🇮Tampere, Finland